MAPK8 and laryngeal carcinoma: Additionally, studies have demonstrated that SOX2 contributes to the progression of laryngeal cancer, where it exerts crucial regulatory effects on apoptosis and metastasis of laryngeal cancer cells through the MAP4K4/JNK signaling pathway [64].